创维(00751.HK)冀全年电视销量录低单位数增幅
创维集团(00751.HK)投资者关系总经理麦美琪表示,疫情对电视销售的影响较其他行业少得多,公司4月起复工复产,因疫情因素上半年未再提及销售目标,但见目前销售转趋稳定,目前客户经营情况不错,存货水平在控制之内,首七个月整体销量按年增长0.8%,当中海外市场恢复较快,增长19.3%,中国市场跌幅收窄至14.6%,冀全年销量可录得低单位数增长。
对於公司未有派发中期股息,她解释,虽然市场情绪有好转,经济前景不明朗,考虑到未来几年考虑公司盈利状况及未来发展资金需求後,决定不派中期息。至於要约回购方面,她预料周四(9月3日)会有回购结果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.